In addition, the loss of tumor suppressors like LKB1 in HER2/neu models further increases mTORC1 activity, accelerating tumor development, which highlights the central role of mTORC1 in HER2/neu-mediated oncogenesis [112]. The gene discussed is ERBB2; the disease is neoplasm.